Latest Healius News & Updates

See the latest news and media coverage for Healius. We track all announcements, press releases, and industry mentions in real time, all in one place.

Healius

Pathology and diagnostic services provider

healius.com.au

Headquarters: Sydney, Australia
Company type: Public company
Number of employees: 5,000–10,000
Industry: Healthcare Facilities & Services

Last updated October 24

Latest news about Healius

In short: Healius reported stronger FY26 earnings amid divestitures and private equity takeover speculation.

Company announcements

October 13 Healius

Healius opens two new healthcare centres

The new Dorevitch sites in Avenel and Seymour expand pathology services to regional Victoria communities.

June 26 Healius

Healius transitions pathology arrangements with Ramsay Health Care subsidiaries

The new national framework covers thirteen hospitals and is expected to generate approximately $45m annual revenue.

May 13 Healius

Healius announces FY 2026 trading update and strategic review

Group EBITDA expected between $259m and $264m; exploring sale of Agilex Biolabs; Federal Budget offers no new pathology funding.

March 31 Healius

Healius Limited reports John Mattick's final director's interest notice

John Mattick ceased as director on 31 March 2026. He holds 4,136 ordinary shares directly and interests in 250,181 shares indirectly.

Media coverage

October 24 The Australian

Healius chair Kathryn McKenzie's comments hint at private equity interest

Healius has given its strongest indication yet that it has been in the cross hairs of private equity after chairman Kathryn McKenzie said at its...

October 22 NT News

Health Check: Despite a sickly Dr AI diagnosis, Healius flags higher earnings

Pathology chain Healius (ASX:HLS) has affirmed its current-year earnings expectations, despite the unhelpful tendency of folk to consult Dr AI rather than their real-life GP.

October 20 Kalkine Media

Is Healius (ASX:HLS) Leaner After Its Biolabs Exit?

Healius agreed to exit Agilex Biolabs to concentrate on pathology, and the market is asking if a leaner group can re-rate.

September 25 Ad Hoc News

Healius share rises by 5.56 percent to 0.38 AUD added? no

The transaction is expected to generate 155 million AUD in cash after separation and transaction costs. Upon completion, Healius expects a net cash position; the execution is scheduled for...

Never miss news about Healius

Track Healius and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Healius competitors & trending companies

Browse news for competitors to Healius and other trending companies.